JCI - Citations to Interruption of the enterohepatic circulation of digitoxin by cholestyramine: II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man

Citations to this article

Interruption of the enterohepatic circulation of digitoxin by cholestyramine: II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man

James H. Caldwell, … , Charles A. Bush, Norton J. Greenberger

James H. Caldwell, … , Charles A. Bush, Norton J. Greenberger

Published December 1, 1971
Citation Information: J Clin Invest. 1971;50(12):2638-2644. https://doi.org/10.1172/JCI106764.

View: Text | PDF

Total citations by year

Year:	2016	2015	2006	2001	1997	1996	1995	1994	1992	1991	1990	1988	1987	1986	1985	1984	1983	1982	1981	1980	1979	1978	1977	1976	1975	1974	1973	1972	1971	1962	Total
Citations:	1	1	1	1	1	2	1	3	1	1	2	1	3	1	3	5	4	4	3	2	1	2	4	3	5	1	3	1	1	1	63

Citation information

Citations to this article (63)

Title and authors	Publication	Year
Role of enterohepatic recirculation in drug disposition: cooperation and complications MY Malik, S Jaiswal, A Sharma, M Shukla, J Lal	Drug Metabolism Reviews	2016
Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids CD Klaassen, JY Cui	Drug metabolism and disposition: the biological fate of chemicals	2015
Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal DM Roberts, E Southcott, JM Potter, MS Roberts, M Eddleston, NA Buckley	Therapeutic Drug Monitoring	2006
Treatment of congestive heart failure - current status of use of digitoxin GG Belz, K Breithaupt-Grogler, U Osowski	European Journal of Clinical Investigation	2001
A Manual of Adverse Drug Interactions JP Griffin, PF D'Arcy	A Manual of Adverse Drug Interactions	1997
Effects of Cholestyramine and Parenteral Nutrition on Hepatic Metabolism of Lidocaine: A Study Using Isolated Rat Liver Perfusion N Zaman, YK Tam, LD Jewel, RT Coutts	JPEN. Journal of parenteral and enteral nutrition	1996
Mechanisms of Drug Interactions PF DArcy, JC McElnay, PG Welling		1996
Cardiac Glycosides Drug Interactions of Clinical Significance: B Magnani, PL Malini	Drug Safety	1995
The effect of colestipol and cholestyramine on ibuprofen bioavailability in man MA Al-Meshal, YM El-Sayed, SR Al-Balla, MW Gouda	Biopharmaceutics & Drug Disposition	1994
Principles and Treatment of Lipoprotein Disorders G Schettler, AJ Habenicht		1994
Hagers Handbuch der Pharmazeutischen Praxis M Albinus, G Amschler, U Amschler, E von Angerer, W Barthel, A Bauer, K Bauer, J Beckmann, W Beil, J Beitz, P Berscht, T Beyrich, K Binder, R Böhme, HH Borchert, F Bracher, H Bräunlich, K Brinkmann, F von Bruchhausen, K Brune, A Büge, W Christ, M Cimbollek, R Daniels, G Dannhardt, HJ Duchstein, S Ebel, K Eger, P Emig, T Erker, MS Fernandez-Alfonso, AW Frahm, M Frahm, KJ Freundt, D Geffken, U Geis, E Glusa, B Göber, J Gödicke, M Goppelt-Strübe, W Gössling, A Graul, S Greiner, A Grisk, M Grosam, M von Gruchalla, M Gütschow, A Haberkorn, E Hackenthal, A Häfner, B Haluszczynski, A Harder, S Hartmann, S Hartmann, D Heber, G Heinemeyer, A Hensel, S Hoedt-Schmidt, H Hoffmann, U Hoffmann-Schollmayer, U Holzgrabe, M Hug, W Ibrom, E Inkmann, J Jürgens, B Kaiser, DA Kalbhen, N Khudeir, W Kiefer, D Kleinsorge, C Klett, S Klett, M Klingmüller, HP Klöcking, G Kobal, A Kramer, M Kreher, G Kreutz, R Kroker, D Landsiedel-Maier, J Lehmann, MS Lehner, S Leiner, H Löwe, J Mann, D Manns, W Matthiessen, A Maurer, W Meindl, K Menges, P Messinger, HJ Mest, FP Meyer, J Mollière, R Morgenstern, W Morick, J Mössner, C Müller, D Müller, K Müller, W Müller, A Mülsch, T Netzer, M Neugebauer, U Niemeyer, P Nuhn, B Nürnberg, J Oertel, M Oettel, H Oßwald, R Ott, T Ott, T Otzen, P Pachaly, H Pelzer, KU Petersen, M Pickert, A Pies, K Pietrzik, D Preiss, H Priewer, O Queckenberg, E Reimann, J Remien, R Rettig, A Reymann, J Richter, H Rommelspacher, U Rose, G Rücker, K Schaefer, H Schlager, W Schleicher, H Schleinitz, W Schlichter, H Schmidhammer, G Schmidt, T Schmidt, J Schräder, T Schulz, G Schulze, P Schwanz, H Schwilden, M Serke, G Skopp, M Spohn, R Stahlmann, JP Stasch, C Steffen, J Steinmeyer, KH Surborg, U Sürig, I Szelenyi, R Troschütz, M Verborg, EJ Verspohl, FJ Volk, H Walther, H Weber, J Wede, M Wenzel, M Weyandt-Spangenberg, S Wich, H Winterhoff, R Wintersteiger, F Woltmann, D Youssef, A Ziegler		1994
Modern Concepts in Gastroenterology Volume 3 AB Thomson, E Shaffer		1992
A Comparative Review of the Adverse Effects of Treatments for Hyperlipidaemia: A Steiner, B Weisser, W Vetter	Drug Safety	1991
Interruption of the enterohepatic circulation of indomethacin by cholestyramine in rabbits MA Al-Meshal, YM El-Sayed, AA Al-Angary, KM Lutfi, MW Gouda	International Journal of Pharmaceutics	1990
Apparent Reduced Absorption of Gemfibrozil When Given with Colestipol SC Forland, Y Feng, RE Cutler	The Journal of Clinical Pharmacology	1990
Pharmacokinetic Interactions with Digoxin: SM Rodin, BF Johnson	Clinical Pharmacokinetics	1988
Pharmacological treatment of lipid disorders in diabetes mellitus MF Lopes-Virella, JA Colwell	Diabetes / Metabolism Reviews	1987
Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phosphorylation Calcium-Activated Neutral Protease Microbial Iron Transport Pharmacokinetic Drug Interactions WR Bartle, V Braun, JM Dietschy, Y Emori, M Hagiwara, H Hidaka, S Imajoh, H Kawasaki, JB Meddings, S Ohno, K Suzuki, SE Walker, G Winkelmann, NE Winslade		1987
Adverse Effects of Hypolipidaemic Drugs LC Knodel, RL Talbert	Medical Toxicology	1987
Topics in Clinical Pharmacology and Therapeutics RF Maronde		1986
Pharmacokinetics, bioavailability and serum levels of cardiac glycosides TW Smith	Journal of the American College of Cardiology	1985
Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man MN Cayen	Pharmacology & Therapeutics	1985
New Advances in the Assessment and Treatment of Digitalis Toxicity TW Smith	The Journal of Clinical Pharmacology	1985
Enhancement of Xenobiotic Elimination: Role of Intestinal Excretion ZH Israili, PG Dayton	Drug Metabolism Reviews	1984
Part III Digitalis glycosides: Mechanisms and manifestations of toxicity TW Smith, EM Antman, PL Friedman, CM Blatt, JD Marsh	Progress in Cardiovascular Diseases	1984
Part II Digitalis glycosides: Mechanisms and manifestations of toxicity TW Smith, EM Antman, PL Friedman, CM Blatt, JD Marsh	Progress in Cardiovascular Diseases	1984
Part I Digitalis glycosides: Mechanisms and manifestations of toxicity TW Smith, EM Antman, PL Friedman, CM Blatt, JD Marsh	Progress in Cardiovascular Diseases	1984
Interactions Affecting Drug Absorption: PG Welling	Clinical Pharmacokinetics	1984
Cholestyramine Resin in the Treatment of Digitoxin Toxicity AM Baciewicz, ML Isaacson, GL Lipscomb		1983
Effect of cholestyramine and colestipol on the absorption of phenytoin JT Callaghan, M Tsuru, JL Holtzman, DB Hunninghake	European Journal of Clinical Pharmacology	1983
Wandlungen in der Therapie der Herzinsuffizienz N Rietbrock, B Schnieders, J Schuster		1983
Therapie mit Herzglykosiden E Erdmann		1983
Digitalis KO Haustein	Pharmacology & Therapeutics	1982
DRUG INTERACTIONS INVOLVING DIGITALIS GLYCOSIDES BF Johnson, DR Urbach	Drug Metabolism and Drug Interactions	1982
Effect of Administration of Activated Charcoal and Fibre on Absorption, Excretion and Steady State Blood Levels of Digoxin and Digitoxin. Evidence for Intestinal Secretion of the Glycosides P Reissell, V Manninen	Acta Medica Scandinavica	1982
Digitalistherapie bei Nieren- und Leberinsuffizienz N Rietbrock, H Kleinfelder		1982
Anaesthetic problems associated with the treatment of cardiovascular disease: I. digitalis toxicity DC Chung	Canadian Anaesthetists’ Society Journal	1981
Acute, Massive Poisoning with Digitoxin: Report of Seven Cases and Discussion of Treatment V Hansteen, D Jacobsen, K Knudsen, Å Reikvam, BJ Skuterud	Clinical Toxicology	1981
A standard approach to compiling clinical pharmacokinetic data LB Sheiner, LZ Benet, LA Pagliaro	Journal of Pharmacokinetics and Biopharmaceutics	1981
Sites and mechanisms of drug interactions I. In vitro, intestinal and metabolic interactions JC McElnay, PF D'Arcy	International Journal of Pharmaceutics	1980
Metabolic Disposition of Antihyperlipidemic Agents in Man and Laboratory Animals MN Cayen	Drug Metabolism Reviews	1980
Utilisation of digitalis glycosides: The relevance of their biotransformation DJ Temple, DW Harron, PS Collier	International Journal of Pharmaceutics	1979
Probable interaction of loperamide and cholestyramine TY Ti, HG Giles, EM Sellers	Canadian Medical Association journal	1978
Clinical Pharmacokinetics of Hypolipidaemic Drugs: R Gugler	Clinical Pharmacokinetics	1978
Reversal of Advanced Digitoxin Toxicity and Modification of Pharmacokinetics by Specific Antibodies and Fab Fragments HR Ochs, TW Smith	Journal of Clinical Investigation	1977
Klinische und pharmakokinetische Untersuchungen zur Digitalisintoxikation G Bodem, HJ Gilfrich, H Aulepp, H Ochs, HJ Dengler	Klinische Wochenschrift	1977
Digitalis intoxication and poisoning HS Schwartz	Journal of the American College of Emergency Physicians	1977
Clinical Pharmacokinetics of Digitoxin: D Perrier, M Mayersohn, FI Marcus	Clinical Pharmacokinetics	1977
CLINICAL PRINCIPLES OF DRUG INTERACTIONS IN THE ADULT PATIENT A Hurwitz†, DL Azarnoff	Annals of the New York Academy of Sciences	1976
Mechanisms of Toxicity and Metabolism RL Smith, P Millburn	Mechanisms of Toxicity and Metabolism	1976
Digitalis Assay and Its Clinical Application S Oparil	Medical Clinics of North America	1976
Lack of Effect of Cholestyramine on the Pharmacokinetics of Clofibrate in Man A Sedaghat, EH Ahrens	European Journal of Clinical Investigation	1975
Biliary Excretion of Xenobiotics CD Klaassen, GL Plaa	Critical Reviews in Toxicology	1975
The Single Dose Method of Administering Cholestyramine HR Casdorph	Angiology	1975
Potential Drug Interactions— Fact or Fallacy? CD Black, NG Popovich		1975
Digitalistherapie H Jahrmärker		1975
Current concepts of therapy with digitalis glycosides. Part II D Schick, J Scheuer	American Heart Journal	1974
ILEAL BYPASS IN THE TREATMENT OF HYPERLIPOPROTEINÆMIA GR Thompson, AM Gotto	The Lancet	1973
New developments and therapeutic applications of cardiac stimulating agents JF Williams	The American Journal of Cardiology	1973
Determination of bioavailability of digitoxin using the radioimmunoassay procedure RG Stoll, MS Christensen, E Sakmar, D Blair, JG Wagner	Journal of Pharmaceutical Sciences	1973
Contribution of Quantitative Assay Technics to the Understanding of the Clinical Pharmacology of Digitalis TW Smith	Circulation	1972
Drug Interactions RF Palmer	Medical Clinics of North America	1971
Cardiac Glycosides DG Friend	New England Journal of Medicine	1962

Advertisement